Skip to content

Safety evaluation of the Hou GuMi Xi (HGMX) which is modified from Shen Ling Bai Zhu San in general population.

Safety evaluation of the Hou GuMi Xi (HGMX) which is modified from Shen Ling Bai Zhu San in general population.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004164
Enrollment
Unknown
Registered
2020-09-29
Start date
2020-09-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy person

Interventions

Sponsors

Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged >=18 years old general population, men and women are not limited; (2) Voluntary participation and the signing of informed consent;

Exclusion criteria

Exclusion criteria: (1) Nearly one year to prepare for pregnancy, pregnant or lactating women; (2) Allergic constitution or to the sample of known components (ginseng, poria, liquorice, coix seed, Chinese yam, lotus seed, sand kernel, platycodon, orange peel, white lentil, oatmeal, japonica rice) allergy; (3) mental, cognitive, consciousness disorders can not cooperate with the completion of the test; (4) Combined with serious heart, brain and hematopoietic system and other primary diseases, combined with serious liver and kidney damage, pulmonary infection, malignant tumor and mental disease patients;Such as acute or subacute severe hepatitis, chronic liver failure decompensation period, end-stage renal disease, systemic lupus erythematosus (sle) complicated with severe renal impairment, acute myocardial infarction, severe primary cardiomyopathy, severe type 1 diabetes, malignant tumor, severe aplastic anemia, severe idiopathic pulmonary hypertension; (5) have been involved in other researchers.

Design outcomes

Primary

MeasureTime frame
Electrocardiograph;Detection of intestinal flora metabolites;adverse reaction;Metabolomics of human serum and urine;hepatic and renal function;stool routine examination;routine urianlysis;The species and quantity level detection of human intestinal flora;blood routine examination;four blood coagulation indexes;

Countries

China

Contacts

Public ContactJian hui
13870065130@126.com+86 13870065130

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026